Eli Lilly and Company
Eli Lilly and Company (LLY.TO) Revenue
Annual & quarterly revenue history · segment & region breakdown
LLY.TO · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsEli Lilly and Company trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Eli Lilly and Company receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Eli Lilly and Company reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Eli Lilly and Company's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
LLY.TO revenue · 4 questionsLLY.TO's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Eli Lilly and Company SEC filings · GAAP · Eli Lilly and Company SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026